Clinical Trials Directory

Trials / Completed

CompletedNCT02739932

Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study

Status
Completed
Phase
Study type
Observational
Enrollment
243 (actual)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
12 Years – 25 Years
Healthy volunteers
Accepted

Summary

The primary study aims are to determine the clinical, behavioural and social predictors of SMI development in youth, and to investigate whether neuroimaging can distinguish youth who will develop SMI from those who will not. The study's secondary aims are to examine the proportions of the cohort that make transitions between the different clinical stages of risk, and to determine the proportions that have poor outcomes, defined as ongoing or increased symptoms, secondary substance misuse, poor social or role functioning, i.e., non-participation in education, or employment, and new self-harm. Investigators will study a cohort of 240 youth (aged 14-25, male and female) that includes youth with early mood symptoms or sub-threshold psychotic symptoms (symptomatic group; n=160), youth at risk due to a family history of a SMI (family high risk (FHR); n=40), and healthy controls (HC; n=40). From this cohort, clinical, social and cognitive data, as well as imaging data will be gathered to create a multi-layered "snapshot" of these individuals and provide full-level characterization. Investigators will use the full range of clinical and imaging data generated from this cohort to develop novel prediction algorithms incorporating key variables that predict the development of SMI.

Conditions

Timeline

Start date
2015-03-01
Primary completion
2021-08-01
Completion
2021-08-01
First posted
2016-04-15
Last updated
2022-05-24

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02739932. Inclusion in this directory is not an endorsement.